Back
Speaker illustration

Mr Venk Varadan

Maimonides Medical Center, Brooklyn (United States of America)

Venk is the co-founder and CEO of Nanowear, a New York-based connected-care and companion diagnostics technology platform built upon first-of-its-kind cloth-based nanosensors. Nanowear was founded in September 2014 and received its first FDA 510(k) Class II clearance in December 2016 establishing Nanowear as the first-and-only company in the world to receive this accreditation for cloth-nanotechnology-based remote monitoring. Before Nanowear, Venk spent ~7 years in Technology Investment Banking, focusing exclusively on venture-backed software and communications technology in which he successfully advised growth companies in over $3bn USD worth of transactions at UBS Investment Bank, Citadel Investment Group and Wells Fargo Securities in New York. Prior to his finance career, Venk spent ~ 3 years in product marketing and sales at Eli Lilly and Sanofi Aventis Pharmaceuticals in New York. Venk received his MBA from Columbia University and his BSE from Duke University.

Presentations

Upstream detection and digital alerts of worsening heart failure using non-invasive cloth-based nanotechnology .

Event: Digital Health 2019

Topic: Remote Patient Monitoring and Telehealth

Session: Remote monitoring for Chronic Heart Failure 2

Access
Thumbnail

Nanowear SimpleSense / a cloth-based connected-self technology and analytics platform for Congestive Heart Failure management and diagnostic alerts.

Event: ESC Congress 2018

Topic: e-Cardiology/Digital Health

Session: Big Data

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb